Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: EC:3.4.21.73 (urokinase-type plasminogen activator)
 10,685 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Microaggregates are formed during the storage of human blood and are composed largely of platelets and leukocytes. These microparticles reside in the buffy coat fraction of blood. The formation of microaggregates can be successfully prevented by removal of the buffy coat or by treatment of blood with drugs which inhibit platelet function prior to storage. Once formed, the volumes of microaggregates in aged blood can be significantly reduced by washing, centrifugation or treatment with urokinase or streptokinase. Glycerol frozen red blood cells and blood components--packed red blood cells and plasma--are free of microaggregates, and they can be infused without fear of embolic consequence.
 ...
PMID:The source and removal of microaggregates in aged human blood and human blood components. 116 87

A patient with nephrotic syndrome developed pseudotumor cerebri following glucocorticoid therapy. Diagnosis of pseudotumor cerebri was based on satisfaction of four criteria proposed by Ahlskog and O'Neill. The symptoms of pseudotumor cerebri disappeared within 10 days. After a three-week interval of remission, relapse occurred. Glycerol and urokinase produced rapid resolution of the symptoms and warfarin prevented further recurrence of pseudotumor cerebri for one year. These results suggest that the pathogenesis of pseudotumor cerebri might be associated with the hypercoagulable state which was induced by glucocorticoid therapy and nephrotic syndrome.
 ...
PMID:A case of pseudotumor cerebri following glucocorticoid therapy in which warfarin prevented recurrence. 208 86